A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease, according to findings ...

A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...

A new study by UCLA Health has discovered what researchers say is the first drug to fully reproduce the effects of physical ...

Epithelial cells defend human skin and mucous membranes. Specialized structures known as “junctions” enable this “barrier” tissue to carry out its role. They control interactions between cells and ...

Our skin and mucous membranes are protected by epithelial cells. This 'barrier' tissue performs its function thanks to specialized structures called 'junctions'. They ensure cell cohesion and regulate ...

A drug has been identified that mimics the effects of physical stroke rehabilitation, offering hope for stroke recovery ...

Our skin and mucous membranes protect us like vigilant sentinels against the onslaught of harmful pathogens. This extraordinary defense owes its strength to epithelial cells—specialized tissues woven ...

There's newfound hope for stroke patients in recovery, with what researchers believe is the very first drug that can ...

A new study has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice, following from human studies.

Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, a new study demonstrates how some cancer cells use the protein ...

St. Jude researchers identified a protein, voltage-dependent anion channel 2 (VDAC2), that tumors use as a “signal jammer” to prevent cancer cell death and evade the immune system’s functioning.